Summary of Study ST000138
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000123. The data can be accessed directly via it's Project DOI: 10.21228/M8PC7J This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST000138 |
| Study Title | Targeted LC MS of acylcarnitines: TLCMS |
| Study Summary | Acylcarnitines (panel of 66 quantitated acylcarnitines) analyzed by LC/MS/MS using flow injection analysis with electrospray ionization |
| Institute | University of Florida |
| Department | Pharmacotherapy and Translational Research |
| Last Name | Cooper-DeHoff |
| First Name | Rhonda |
| dehoff@cop.ufl.edu | |
| Submit Date | 2015-01-08 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | d |
| Uploaded File Size | 1.3 G |
| Analysis Type Detail | LC-MS |
| Release Date | 2016-06-18 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR000159 |
| Treatment Summary: | Atenolol was initiated at 50mg, and titrated to 100mg, based on BP > 120/70 mmHg and tolerability. Blood samples were collected prior to initiation of atenolol treatment and after at least 6 weeks on the final dose. Blood samples were spun and serum and plasma fractions stored at -80C. Treatment: Intervention Treatment Compound: Atenolol Treatment Dose: 50mg titrated to 100mg based on BP and tolerability Treatment Dose Duration: Minimum of 6 weeks |
